Mostafa Ronaghi net worth and biography

Mostafa Ronaghi Biography and Net Worth

SVP of Illumina
Dr. Mostafa Ronaghi, Ph.D., has been the Chief Technology Officer and Senior Vice President of Illumina Inc. since 2008 and is responsible for leading internal research and the Illumina accelerator program. Dr. Ronaghi is a Co-Founder of Illumina Accelerator Program. Dr. Ronaghi co-founded NextBio, Inc., in 2004 and served as its Chairman of Scientific Advisory Board. He co-founded Pyrosequencing AB (now Biotage) in Uppsala, Sweden in 1997. He co-founded ParAllele BioScience Inc. in 2001. He co-founded Avantome, Inc. He is an experienced life sciences entrepreneur and was involved in the start-up of four life sciences companies. He served as Principal Investigator of Stanford University Genome Center focused on development of novel tools for molecular diagnostics applications from 2002 to 2008. He is known internationally for his work in DNA-based technologies. He serves as a Member of the Scientific Advisory Board at IntegenX Inc. (formerly, Microchip Biotechnologies, Inc). Dr. Ronaghi serves as a Director of Aurora Algae, Inc. (formerly, Aurora BioFuels Inc) and Clear Labs, Inc. He serves as a Member of Scientific Advisory Board of GRAIL, Inc. Dr. Ronaghi served as a Member of Scientific Advisory Board at ParAllele Bioscience, Inc. He served as a Director of IntegenX Inc. since October 31, 2006. He holds more than 50 pending and issued patents and has written more than 70 peer-reviewed publications in journals and books. Dr. Ronaghi received his PhD from Royal Institute of Technology in Sweden.

What is Mostafa Ronaghi's net worth?

The estimated net worth of Mostafa Ronaghi is at least $18.35 million as of December 10th, 2020. Ronaghi owns 83,862 shares of Illumina stock worth more than $18,345,651 as of December 3rd. This net worth approximation does not reflect any other investments that Ronaghi may own. Learn More about Mostafa Ronaghi's net worth.

How do I contact Mostafa Ronaghi?

The corporate mailing address for Ronaghi and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected] Learn More on Mostafa Ronaghi's contact information.

Has Mostafa Ronaghi been buying or selling shares of Illumina?

Mostafa Ronaghi has not been actively trading shares of Illumina in the last ninety days. Most recently, Mostafa Ronaghi sold 5,000 shares of the business's stock in a transaction on Thursday, December 10th. The shares were sold at an average price of $338.58, for a transaction totalling $1,692,900.00. Following the completion of the sale, the senior vice president now directly owns 83,862 shares of the company's stock, valued at $28,393,995.96. Learn More on Mostafa Ronaghi's trading history.

Who are Illumina's active insiders?

Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.

Are insiders buying or selling shares of Illumina?

In the last year, insiders at the life sciences company sold shares 12 times. They sold a total of 8,309 shares worth more than $2,739,762.78. The most recent insider tranaction occured on November, 7th when SVP Susan H Tousi sold 500 shares worth more than $111,825.00. Insiders at Illumina own 0.1 % of the company. Learn More about insider trades at Illumina.

Information on this page was last updated on 11/7/2022.

Mostafa Ronaghi Insider Trading History at Illumina

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/10/2020Sell5,000$338.58$1,692,900.0083,862View SEC Filing Icon  
10/15/2019Sell4,000$310.93$1,243,720.0080,585View SEC Filing Icon  
9/16/2019Sell10,000$300.53$3,005,300.0086,585View SEC Filing Icon  
8/15/2019Sell10,000$285.52$2,855,200.0086,585View SEC Filing Icon  
7/15/2019Sell10,000$302.04$3,020,400.0086,776View SEC Filing Icon  
6/17/2019Sell10,000$349.28$3,492,800.0065,994View SEC Filing Icon  
5/15/2019Sell10,000$305.49$3,054,900.0087,414View SEC Filing Icon  
11/12/2018Sell10,000$314.63$3,146,300.0079,612View SEC Filing Icon  
10/10/2018Sell10,000$311.84$3,118,400.0080,805View SEC Filing Icon  
9/10/2018Sell10,000$347.07$3,470,700.0080,805View SEC Filing Icon  
8/10/2018Sell10,000$331.39$3,313,900.00View SEC Filing Icon  
7/10/2018Sell7,500$288.89$2,166,675.0078,496View SEC Filing Icon  
6/11/2018Sell10,500$284.83$2,990,715.0081,496View SEC Filing Icon  
5/16/2018Sell10,000$267.71$2,677,100.0080,996View SEC Filing Icon  
9/7/2017Sell20,000$210.00$4,200,000.0086,725View SEC Filing Icon  
8/2/2017Sell10,000$195.00$1,950,000.0076,585View SEC Filing Icon  
7/17/2015Sell1,200$235.00$282,000.00View SEC Filing Icon  
7/15/2015Sell3,000$227.19$681,570.00View SEC Filing Icon  
12/1/2014Sell10,000$188.46$1,884,600.00View SEC Filing Icon  
11/3/2014Sell10,000$195.66$1,956,600.00View SEC Filing Icon  
10/1/2014Sell10,000$159.81$1,598,100.00View SEC Filing Icon  
9/2/2014Sell10,000$179.66$1,796,600.00View SEC Filing Icon  
8/1/2014Sell10,000$159.73$1,597,300.00View SEC Filing Icon  
7/1/2014Sell10,000$179.47$1,794,700.00View SEC Filing Icon  
6/2/2014Sell10,000$156.93$1,569,300.00View SEC Filing Icon  
5/1/2014Sell10,000$135.91$1,359,100.0028,604View SEC Filing Icon  
4/1/2014Sell10,000$152.41$1,524,100.0028,604View SEC Filing Icon  
7/11/2013Sell24,000$74.95$1,798,800.00View SEC Filing Icon  
6/11/2013Sell24,000$69.01$1,656,240.00View SEC Filing Icon  
5/13/2013Sell24,000$68.83$1,651,920.00View SEC Filing Icon  
See Full Table

Mostafa Ronaghi Buying and Selling Activity at Illumina

This chart shows Mostafa Ronaghi's buying and selling at Illumina by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Illumina Company Overview

Illumina logo
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Read More

Today's Range

Now: $218.76
Low: $211.00
High: $219.55

50 Day Range

MA: $214.81
Low: $184.12
High: $242.74

2 Week Range

Now: $218.76
Low: $173.45
High: $428.00


1,086,361 shs

Average Volume

1,326,745 shs

Market Capitalization

$34.41 billion

P/E Ratio


Dividend Yield